Corporate DNA testing could put our genetic privacy at risk

Print Friendly, PDF & Email

There is another aspect of 23andMe’s business, one which has received less attention from the media (with the exception of an excellent writeup in Scientific American by Charles Seife), but which is, in actuality, both equally troubling and equally fascinating.

“The long game here is not to make money selling kits, although the kits are essential to get the base-level data,” said Patrick Chung, a 23andMe board member. And the company’s privacy policy, it’s worth noting, makes no promises that it will not share aggregate-level genetic data with its vendors and affiliates, such as the company that manufactures the chips used in processing saliva samples.

Read the full, original story: A genetic “Minority Report”: How corporate DNA testing could put us at risk

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Trending green and going great — Every state in the US seeing decreased cases of COVID

Infographic: Trending green and going great — Every state in the US seeing decreased cases of COVID

The U.S. averaged fewer than 40,000 new cases per day over the past week. That’s a 21% improvement over the ...
a bee covered in pollen x

Are GMOs and pesticides threatening bees?

First introduced in 1995, neonicotinoids ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists